[go: up one dir, main page]

AR086207A1 - Composiciones y metodos - Google Patents

Composiciones y metodos

Info

Publication number
AR086207A1
AR086207A1 ARP120101505A ARP120101505A AR086207A1 AR 086207 A1 AR086207 A1 AR 086207A1 AR P120101505 A ARP120101505 A AR P120101505A AR P120101505 A ARP120101505 A AR P120101505A AR 086207 A1 AR086207 A1 AR 086207A1
Authority
AR
Argentina
Prior art keywords
compositions
methods
peg
disclosed
ccecc
Prior art date
Application number
ARP120101505A
Other languages
English (en)
Original Assignee
Univ Northshore Healthsystem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northshore Healthsystem filed Critical Univ Northshore Healthsystem
Publication of AR086207A1 publication Critical patent/AR086207A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/10—Saturated ethers of polyhydroxy compounds
    • C07C43/11—Polyethers containing —O—(C—C—O—)n units with ≤ 2 n≤ 10
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se revelan composiciones que comprenden polietilenglicol (PEG) para la profilaxis y/o el tratamiento de carcinomas de células escamosas de cabeza y cuello (CCECC). Se revelan además métodos para la profilaxis y/o el tratamiento de CCECC, que comprenden la administración de una cantidad eficaz de PEG. Asimismo, se revelan métodos y composiciones para la supresión de la expresión de superficie de EGFR usando PEG.
ARP120101505A 2011-04-27 2012-04-27 Composiciones y metodos AR086207A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161479493P 2011-04-27 2011-04-27

Publications (1)

Publication Number Publication Date
AR086207A1 true AR086207A1 (es) 2013-11-27

Family

ID=47072771

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101505A AR086207A1 (es) 2011-04-27 2012-04-27 Composiciones y metodos

Country Status (14)

Country Link
US (1) US20140050724A1 (es)
EP (1) EP2702030A4 (es)
JP (1) JP2014513103A (es)
KR (1) KR20140033370A (es)
CN (1) CN103619792A (es)
AR (1) AR086207A1 (es)
AU (1) AU2012249494A1 (es)
BR (1) BR112013027369A2 (es)
CA (1) CA2834395A1 (es)
EA (1) EA201301205A1 (es)
MX (1) MX2013012337A (es)
TW (1) TW201311255A (es)
WO (1) WO2012149302A1 (es)
ZA (1) ZA201308892B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2753933B1 (en) * 2011-09-09 2017-08-09 Amgen Inc. Use of human papillomavirus status in establishing use of an agent that binds egfr in the treatment of cancer
US20200323811A1 (en) * 2016-05-24 2020-10-15 Industry-University Cooperation Foundation Hanyang University Intranasal pharmaceutical composition comprising anticancer drugcontaining nanoparticles for treating brain diseases
WO2018106456A1 (en) * 2016-12-07 2018-06-14 The Board Of Regents Of The University Of Texas System Mouthwash for treating oral cancers
SG11202008669YA (en) * 2018-03-13 2020-10-29 Innate Pharma Treatment of head and neck cancer
EP3934663B1 (en) 2019-03-05 2024-06-26 Dow Global Technologies LLC Polyethyleneglycol derivatives for use in treating cancer and/or inducing caspase activity
CN112400801B (zh) * 2020-12-07 2022-07-22 天津医科大学第二医院 一种喉癌前病变动物模型及其构建方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006085517A1 (ja) * 2005-02-08 2008-06-26 株式会社光ケミカル研究所 クロリン類及びポルフィリン類のｐｄｔ用軟膏製剤及び坐剤
US9173835B2 (en) * 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
CN101147725B (zh) * 2006-09-21 2012-05-16 杨立新 一种用于阴道给药的酮康唑栓剂组合物
NO346530B1 (no) * 2006-09-28 2022-09-26 Merck Sharp & Dohme Anvendelser av pegylert interleukin-10 (PEG-IL-10) for å forebygge metastaser av kreft eller tumor i lungene.
US20110077263A1 (en) * 2009-09-29 2011-03-31 University Of Southern California Methods and Compositions of Toll-Like Receptor (TLR) Agonists

Also Published As

Publication number Publication date
ZA201308892B (en) 2016-08-31
TW201311255A (zh) 2013-03-16
KR20140033370A (ko) 2014-03-18
WO2012149302A1 (en) 2012-11-01
MX2013012337A (es) 2014-04-16
CN103619792A (zh) 2014-03-05
CA2834395A1 (en) 2012-11-01
EP2702030A1 (en) 2014-03-05
US20140050724A1 (en) 2014-02-20
EA201301205A1 (ru) 2014-04-30
JP2014513103A (ja) 2014-05-29
AU2012249494A1 (en) 2013-05-02
BR112013027369A2 (pt) 2017-01-17
EP2702030A4 (en) 2014-09-10

Similar Documents

Publication Publication Date Title
CY1122329T1 (el) Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων
MX2018005829A (es) Composiciones para tratar el cabello.
MX2012000389A (es) Imidazoles fusionados y composiciones que los comprenden para el tratamiento de enfermedades parasitarias, tales como, por ejemplo, malaria.
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MA39986A (fr) Dérivés de purine en tant qu'inhibiteurs de cd73 pour le traitement du cancer
GT201400111A (es) Triazolopiridinas sustituidas
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
MX2012008717A (es) Composiciones para el cuidado oral.
PH12018500071B1 (en) Plinabulin compositions
MX346730B (es) Composiciones y metodos para el tratamiento de la hipertension pulmonar.
MX2015016406A (es) Formulacion de revestimiento para madera.
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
MX2017003121A (es) Formulaciones de anticuerpos.
ES2572215T3 (es) Anticuerpo neutralizante contra el receptor de prolactina Mat3 y su uso terapéutico
EA201692292A1 (ru) Соединения и композиции для стимулирования хондрогенеза
AR086207A1 (es) Composiciones y metodos
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
DOP2017000146A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
MX2018005158A (es) Compuestos para el tratamiento de trastornos hipoproliferativos.
CL2019002340A1 (es) Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1.
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
CL2018002074A1 (es) Composiciones y métodos para tratar infecciones.

Legal Events

Date Code Title Description
FB Suspension of granting procedure